Back

Safety and efficacy of prolonged antithrombotic therapy in high-risk patients followed in a dedicated secondary prevention consultation

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in preventive cardiology 2 Cardiovascular Rehabilitation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ana Rita Ribeiro Teixeira

University Hospital Lisboa Central, Lisbon (Portugal)

3 More presentations in this session

Presentation thumbnail
Risk profile of patients in a secondary cardiovascular prevention program: thrombotic versus hemorrhagic
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Effects of exercise-based cardiac rehabilitation on left ventricular function in sub-saharan african patients
Doctor N. GAYE (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Gender differences in outcomes following acute coronary syndrome in young adults
Mr P. Mangas Palma (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in preventive cardiology 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Risk profile of patients in a secondary cardiovascular prevention program: thrombotic versus hemorrhagic
thumbnail
Congress Presentation
Prolonged dual antiplatelet therapy in an extended Phase 3 Cardiac Rehabilitation Program following myocardial infarction
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources